{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:15:00Z","timestamp":1789550100058,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Available epidemiological reports on follicular lymphoma (FL) often highlight a significant discrepancy between its high and low incidence rates in Western and Eastern Europe, respectively. The reasons behind that difference are not fully understood, but underreporting is typically presumed as one of the main factors. This study aimed to assess FL epidemiology in Poland based on 2000\u20132014 data from the Polish National Cancer Registry, which has 100% population coverage and over 90% completeness of the registration. All cases were coded according to ICD-10 and ICD-O-3 recommendations. The total number of registered FL cases was 3,928 with crude (CR) and standardized (SR) incidence rates of 0.72\/10<jats:sup>5<\/jats:sup> and 0.87\/10<jats:sup>5<\/jats:sup>, respectively. The median age of FL diagnosis was 61\u00a0years, with the male to female incidence ratio of 1.06. The distribution of morphological types of FL: not otherwise specified (NOS), grades 1, 2, or 3 were 72.58, 4.81, 12.88, and 9.73%, respectively. Among all reported mature B-cell non-Hodgkin lymphomas, FL was ranked the fourth in incidence, just after chronic lymphocytic leukemia\/small lymphocytic lymphoma (CR 3.62\/10<jats:sup>5<\/jats:sup>, SR 4.99\/10<jats:sup>5<\/jats:sup>), plasma cell neoplasms (CR 3.78\/10<jats:sup>5<\/jats:sup>, SR 4.97\/10<jats:sup>5<\/jats:sup>) and diffuse B-cell lymphoma, NOS (CR 2.13\/10<jats:sup>5<\/jats:sup>, SR 2.65\/10<jats:sup>5<\/jats:sup>). The systematic increase in FL incidence among females was observed. Our study confirms a lower FL incidence rate in Poland as compared to other European countries. Moreover, as our analysis was based on a registry with high data completeness, it provides evidence that reasons other than underreporting are responsible for FL incidence discrepancies between Eastern and Western Europe.<\/jats:p>","DOI":"10.1038\/s41598-020-71579-6","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T10:04:10Z","timestamp":1599127450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Population-based epidemiological data of follicular lymphoma in Poland: 15\u00a0years of observation"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-3422","authenticated-orcid":false,"given":"Anna","family":"Szumera-Cie\u0107kiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Wojciechowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-9118","authenticated-orcid":false,"given":"Joanna","family":"Didkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8758-7200","authenticated-orcid":false,"given":"Jan","family":"Poleszczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-8014","authenticated-orcid":false,"given":"Grzegorz","family":"Rymkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Paszkiewicz-Kozik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Sok\u00f3\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Prochorec-Sobieszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Walewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"71579_CR1","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","volume":"116","author":"M Sant","year":"2010","unstructured":"Sant, M. et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116, 3724\u20133734 (2010).","journal-title":"Blood"},{"key":"71579_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","volume":"30","author":"A Miranda-Filho","year":"2019","unstructured":"Miranda-Filho, A. et al. Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes Control CCC 30, 489\u2013499 (2019).","journal-title":"Cancer Causes Control CCC"},{"key":"71579_CR3","first-page":"3280","volume":"7","author":"A Szumera-Cie\u0107kiewicz","year":"2014","unstructured":"Szumera-Cie\u0107kiewicz, A. et al. Distribution of lymphomas in Poland according to World Health Organization classification: analysis of 11718 cases from National Histopathological Lymphoma Register project: the Polish Lymphoma Research Group study. Int. J. Clin. Exp. Pathol 7, 3280\u20133286 (2014).","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"71579_CR4","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues (revised","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow, S. H. et al. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edn. (IARC, Lyon, 2017).","edition":"4"},{"key":"71579_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00428-015-1864-y","volume":"468","author":"L Xerri","year":"2016","unstructured":"Xerri, L. et al. The heterogeneity of follicular lymphomas: from early development to transformation. Virchows Archiv. Int. J. Pathol. 468, 127\u2013139 (2016).","journal-title":"Virchows Archiv. Int. J. Pathol."},{"key":"71579_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","volume":"5","author":"A Carbone","year":"2019","unstructured":"Carbone, A. et al. Follicular lymphoma. Nat. Rev. Dis. Primers 5, 83 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"71579_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1080\/10428190903093815","volume":"50","author":"D de Jong","year":"2009","unstructured":"de Jong, D. & de Boer, J. P. Predicting transformation in follicular lymphoma. Leuk. Lymph. 50, 1406\u20131411 (2009).","journal-title":"Leuk. Lymph."},{"key":"71579_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00277-017-3151-2","volume":"97","author":"T Fischer","year":"2018","unstructured":"Fischer, T., Zing, N. P. C., Chiattone, C. S., Federico, M. & Luminari, S. Transformed follicular lymphoma. Ann. Hematol. 97, 17\u201329 (2018).","journal-title":"Ann. Hematol."},{"key":"71579_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1053\/j.semdp.2017.11.001","volume":"35","author":"N Oishi","year":"2018","unstructured":"Oishi, N., Montes-Moreno, S. & Feldman, A. L. In situ neoplasia in lymph node pathology. Semin. Diagn. Pathol. 35, 76\u201383 (2018).","journal-title":"Semin. Diagn. Pathol."},{"key":"71579_CR10","doi-asserted-by":"crossref","unstructured":"Bray, F., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","DOI":"10.3322\/caac.21492"},{"key":"71579_CR11","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00277-016-2800-1","volume":"95","author":"S Yuda","year":"2016","unstructured":"Yuda, S. et al. Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era. Ann. Hematol. 95, 2017\u20132022 (2016).","journal-title":"Ann. Hematol."},{"key":"71579_CR12","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2015-11-632745","volume":"127","author":"JO Armitage","year":"2016","unstructured":"Armitage, J. O. & Longo, D. L. Is watch and wait still acceptable for patients with low-grade follicular lymphoma?. Blood 127, 2804\u20132808 (2016).","journal-title":"Blood"},{"key":"71579_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/joim.12684","volume":"282","author":"KE Smedby","year":"2017","unstructured":"Smedby, K. E. & Ponzoni, M. The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections. J. Intern. Med. 282, 360\u2013370 (2017).","journal-title":"J. Intern. Med."},{"key":"71579_CR14","doi-asserted-by":"publisher","first-page":"e109332","DOI":"10.1371\/journal.pone.0109332","volume":"9","author":"MCR Alavanja","year":"2014","unstructured":"Alavanja, M. C. R. et al. Non-hodgkin lymphoma risk and insecticide, fungicide and fumigant use in the agricultural health study. PLoS ONE 9, e109332\u2013e109332 (2014).","journal-title":"PLoS ONE"},{"key":"71579_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11356-010-0417-9","volume":"18","author":"J Vijgen","year":"2011","unstructured":"Vijgen, J. et al. Hexachlorocyclohexane (HCH) as new Stockholm Convention POPs: a global perspective on the management of Lindane and its waste isomers. Environ. Sci. Pollut. Res. Int. 18, 152\u2013162 (2011).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"71579_CR16","doi-asserted-by":"crossref","unstructured":"Vijgen, J., de Borst, B., Weber, R., Stobiecki, T. & Forter, M. HCH and lindane contaminated sites: European and global need for a permanent solution for a long-time neglected issue. Environ. Pollut. (Barking, Essex : 1987) 248, 696\u2013705 (2019).","DOI":"10.1016\/j.envpol.2019.02.029"},{"key":"71579_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1586\/14737140.2015.1023712","volume":"15","author":"D Chihara","year":"2015","unstructured":"Chihara, D. et al. New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy. Expert Rev. Anticancer Ther 15, 531\u2013544 (2015).","journal-title":"Expert Rev. Anticancer Ther"},{"key":"71579_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/bjc.2012.333","volume":"107","author":"ME Kroll","year":"2012","unstructured":"Kroll, M. E. et al. Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study. Br. J. Cancer 107, 879\u2013887 (2012).","journal-title":"Br. J. Cancer"},{"key":"71579_CR19","doi-asserted-by":"crossref","unstructured":"Smoking prevalence and attributable disease burden in 195 countries and territories, 1990\u20132015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet (London, England) 389, 1885\u20131906 (2017).","DOI":"10.1016\/S0140-6736(17)30819-X"},{"key":"71579_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2013.284692","volume":"311","author":"M Ng","year":"2014","unstructured":"Ng, M. et al. Smoking prevalence and cigarette consumption in 187 countries, 1980\u20132012. JAMA 311, 183\u2013192 (2014).","journal-title":"JAMA"},{"key":"71579_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jncimonographs\/lgu006","volume":"2014","author":"MS Linet","year":"2014","unstructured":"Linet, M. S. et al. Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J. Natl. Cancer Inst. Monogr. 2014, 26\u201340 (2014).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"71579_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ijc.31330","volume":"143","author":"T Psaltopoulou","year":"2018","unstructured":"Psaltopoulou, T. et al. Alcohol consumption and risk of hematological malignancies: a meta-analysis of prospective studies. Int. J. Cancer 143, 486\u2013495 (2018).","journal-title":"Int. J. Cancer"},{"key":"71579_CR23","unstructured":"World Health Organization. www.who.int\/substance_abuse\/publications\/global_alcohol_report\/profiles\/pol.pdf?ua=1."},{"key":"71579_CR24","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1111\/j.1360-0443.2005.01247.x","volume":"100","author":"B Wojtyniak","year":"2005","unstructured":"Wojtyniak, B., Moskalewicz, J., Stokwiszewski, J. & Rabczenko, D. Gender-specific mortality associated with alcohol consumption in Poland in transition. Addiction (Abingdon, England) 100, 1779\u20131789 (2005).","journal-title":"Addiction (Abingdon, England)"},{"key":"71579_CR25","doi-asserted-by":"crossref","unstructured":"Yakovlev, E. Alcoholism and mortality in Eastern Europe: https:\/\/wol.iza.org\/articles\/alcoholism-and-mortality-in-eastern-europe\/long. in IZA World of Labor (2015).","DOI":"10.15185\/izawol.168"},{"key":"71579_CR26","unstructured":"WHO Global Status Report On Alcohol and Health. Geneva: WHO, 2011."},{"key":"71579_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/aje\/kww118","volume":"185","author":"F Baecklund","year":"2017","unstructured":"Baecklund, F. et al. Possible interaction between cigarette smoking and HLA-DRB1 variation in the risk of follicular lymphoma. Am. J. Epidemiol. 185, 681\u2013687 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"71579_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/ng.626","volume":"42","author":"L Conde","year":"2010","unstructured":"Conde, L. et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat. Genet. 42, 661\u2013664 (2010).","journal-title":"Nat. Genet."},{"key":"71579_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ajhg.2014.09.004","volume":"95","author":"CF Skibola","year":"2014","unstructured":"Skibola, C. F. et al. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region. Am. J. Hum. Genet. 95, 462\u2013471 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"71579_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12881-014-0113-6","volume":"15","author":"F Baecklund","year":"2014","unstructured":"Baecklund, F. et al. A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival. BMC Med Genet 15, 113\u2013113 (2014).","journal-title":"BMC Med Genet"},{"key":"71579_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12032-008-9071-1","volume":"26","author":"E Paszkiewicz-Kozik","year":"2009","unstructured":"Paszkiewicz-Kozik, E. et al. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma. Med. Oncol. (Northwood, London, England) 26, 16\u201321 (2009).","journal-title":"Med. Oncol. (Northwood, London, England)"},{"key":"71579_CR32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/bjh.16264","volume":"188","author":"J Walewski","year":"2020","unstructured":"Walewski, J. et al. First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance: a multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4. Br. J. Haematol. 188, 898\u2013906 (2020).","journal-title":"Br. J. Haematol."},{"key":"71579_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1385\/MO:18:2:141","volume":"18","author":"J Walewski","year":"2001","unstructured":"Walewski, J. et al. Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study. Med. Oncol. (Northwood, London, England) 18, 141\u2013148 (2001).","journal-title":"Med. Oncol. (Northwood, London, England)"},{"key":"71579_CR34","unstructured":"National Cancer Intitute. https:\/\/seer.cancer.gov\/statfacts\/html\/follicular.html. in The Surveillance, Epidemiology, and End Results"},{"key":"71579_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1200\/JCO.18.00400","volume":"37","author":"C Sarkozy","year":"2019","unstructured":"Sarkozy, C. et al. Cause of death in follicular lymphoma in the first decade of the rituximab era: a pooled analysis of French and US cohorts. J. Clin. Oncol. 37, 144\u2013152 (2019).","journal-title":"J. Clin. Oncol."},{"key":"71579_CR36","first-page":"140","volume":"40","author":"A Fritz","year":"2013","unstructured":"Fritz, A. ICD-O-3 terminology approved for use with cases diagnosed January 1, 2014 and after. J. Regis. Manag. 40, 140\u2013143 (2013).","journal-title":"J. Regis. Manag."},{"key":"71579_CR37","unstructured":"https:\/\/icd.who.int\/browse10\/2016\/en#\/C81-C96."},{"key":"71579_CR38","unstructured":"Wojciechowska, U., Olasek, P., Czauderna, K. & Didkowska, J. Nowotwory z\u0142o\u015bliwe w Polsce w 2014 roku. Cancer in Poland in 2014., (Centrum Onkologii Instytut im. Marii Sk\u0142odowskiej-Curie, Warszawa 2016)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71579-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T18:06:51Z","timestamp":1670350011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71579-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["71579"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-71579-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"27 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14610"}}